Literature DB >> 27677500

Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Ayelet Kaminitz1, Shifra Ash1, Nadir Askenasy2.   

Abstract

As physiological pathways of intercellular communication produced by all cells, cytokines are involved in the pathogenesis of inflammatory insulitis as well as pivotal mediators of immune homeostasis. Proinflammatory cytokines including interleukins, interferons, transforming growth factor-β, tumor necrosis factor-α, and nitric oxide promote destructive insulitis in type 1 diabetes through amplification of the autoimmune reaction, direct toxicity to β-cells, and sensitization of islets to apoptosis. The concept that neutralization of cytokines may be of therapeutic benefit has been tested in few clinical studies, which fell short of inducing sustained remission or achieving disease arrest. Therapeutic failure is explained by the redundant activities of individual cytokines and their combinations, which are rather dispensable in the process of destructive insulitis because other cytolytic pathways efficiently compensate their deficiency. Proinflammatory cytokines are less redundant in regulation of the inflammatory reaction, displaying protective effects through restriction of effector cell activity, reinforcement of suppressor cell function, and participation in islet recovery from injury. Our analysis suggests that the role of cytokines in immune homeostasis overrides their contribution to β-cell death and may be used as potent immunomodulatory agents for therapeutic purposes rather than neutralized.

Entities:  

Keywords:  Autoimmunity; Immune homeostasis; Inflammatory insulitis; Proinflammatory cytokines; Regulatory T cells; Type 1 diabetes; β-cell death

Mesh:

Substances:

Year:  2017        PMID: 27677500     DOI: 10.1007/s12016-016-8587-y

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  236 in total

1.  Increased vulnerability of newly forming beta cells to cytokine-induced cell death.

Authors:  J J Meier; R A Ritzel; K Maedler; T Gurlo; P C Butler
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

2.  Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice.

Authors:  Keiichi Kodama; Atul J Butte; Remi J Creusot; Leon Su; Deqiao Sheng; Mark Hartnett; Hideyuki Iwai; Luis R Soares; C Garrison Fathman
Journal:  Clin Immunol       Date:  2008-09-17       Impact factor: 3.969

3.  TNF-α Antibody Therapy in Combination With the T-Cell-Specific Antibody Anti-TCR Reverses the Diabetic Metabolic State in the LEW.1AR1-iddm Rat.

Authors:  Anne Jörns; Ümüs Gül Ertekin; Tanja Arndt; Taivankhuu Terbish; Dirk Wedekind; Sigurd Lenzen
Journal:  Diabetes       Date:  2015-03-17       Impact factor: 9.461

4.  NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.

Authors:  Sunshin Kim; Isabelle Millet; Hun Sik Kim; Ja Young Kim; Myoung Sook Han; Moon-Kyu Lee; Kwang-Won Kim; Robert S Sherwin; Michael Karin; Myung-Shik Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 5.  Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?

Authors:  A Rabinovitch
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

6.  Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).

Authors:  Hilka Rauert; Andreas Wicovsky; Nicole Müller; Daniela Siegmund; Volker Spindler; Jens Waschke; Christian Kneitz; Harald Wajant
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

7.  In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.

Authors:  S V Pakala; M Chivetta; C B Kelly; J D Katz
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

8.  The role of TNF-α in mice with type 1- and 2- diabetes.

Authors:  Maria Koulmanda; Manoj Bhasin; Zuheir Awdeh; Andi Qipo; Zhigang Fan; Dusan Hanidziar; Prabhakar Putheti; Hang Shi; Eva Csizuadia; Towia A Libermann; Terry B Strom
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

9.  Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Authors:  Juliet A Emamaullee; Joy Davis; Shaheed Merani; Christian Toso; John F Elliott; Aducio Thiesen; A M James Shapiro
Journal:  Diabetes       Date:  2009-03-16       Impact factor: 9.461

10.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.

Authors:  Y Higuchi; P Herrera; P Muniesa; J Huarte; D Belin; P Ohashi; P Aichele; L Orci; J D Vassalli; P Vassalli
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.